The Clorox Company (NYSE:CLX – Get Free Report) has been given a consensus recommendation of “Reduce” by the eighteen research firms that are currently covering the firm, MarketBeat.com reports. Five research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $144.67.
Several brokerages recently issued reports on CLX. DA Davidson reissued a “neutral” rating and set a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. JPMorgan Chase & Co. cut their price objective on shares of Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Finally, Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective for the company in a report on Tuesday, March 26th.
Check Out Our Latest Report on Clorox
Hedge Funds Weigh In On Clorox
Clorox Trading Up 1.2 %
NYSE:CLX opened at $136.40 on Thursday. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The firm has a fifty day simple moving average of $134.74 and a 200-day simple moving average of $143.20. Clorox has a 12 month low of $114.68 and a 12 month high of $169.14. The company has a market capitalization of $16.94 billion, a P/E ratio of 70.67, a PEG ratio of 2.00 and a beta of 0.39.
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter last year, the company posted $1.51 earnings per share. The firm’s revenue was down 5.3% compared to the same quarter last year. On average, equities research analysts anticipate that Clorox will post 5.91 earnings per share for the current year.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- MarketBeat Week in Review – 7/8 – 7/12
- Why Invest in 5G? How to Invest in 5G Stocks
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- NYSE Stocks Give Investors a Variety of Quality Options
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.